• Users Online: 5434
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| October-December  | Volume 4 | Issue 4  
    Online since December 29, 2021

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
MUSINGS
With the emergence of Omicron, SARS-CoV-2 is getting weaker and human species is getting stronger due to our inherent cellular intelligence
Pankaj Chaturvedi, Rajendra A Badwe
October-December 2021, 4(4):608-610
DOI:10.4103/crst.crst_313_21  
  1,795 116 -
RESIDENT CORNER
The dwindling art of bedside teaching: Lest we forget
Ghazal Tansir
October-December 2021, 4(4):723-725
DOI:10.4103/crst.crst_262_21  
  595 15 -
ORIGINAL ARTICLES
Correlation of pathological complete response with outcomes in locally advanced breast cancer treated with neoadjuvant chemotherapy: An ambispective study
Priyanshu Choudhary, Ajay Gogia, S V. S Deo, Dayanand Sharma, Sandeep R Mathur, Atul Batra, Hari Krishna Raju Sagiraju
October-December 2021, 4(4):611-620
DOI:10.4103/crst.crst_197_21  
  496 58 -
MUSINGS
Let us give our patients a chance to decide about their treatment: Reiterating patient autonomy
Priya Iyer
October-December 2021, 4(4):605-607
DOI:10.4103/crst.crst_231_21  
  492 54 -
ORIGINAL ARTICLES
Clinical profile and outcomes of malignant melanoma in patients from an Indian institute: A retrospective analysis
Sorun Shishak, Abhenil Mittal, Harshal Aswar, Rambha Pandey, Kaushal Kalra, Aarushi Gupta, Adarsh Barwad, Ekta Dhamija, Shamim Ahmed Shamim, Aditi Aggarwal, Soorej Balan Kaliyath, Sameer Rastogi
October-December 2021, 4(4):621-627
DOI:10.4103/crst.crst_25_21  
  475 57 -
A multicenter, double-blind, randomized phase III trial of ramucirumab plus docetaxel versus placebo plus docetaxel for treatment of Stage IV non-small cell lung cancer after disease progression on or after platinum-based therapy (REVEL): An Indian patient subgroup analysis
Kumar Prabhash, DC Doval, Bharath Rangarajan, Naresh Somani, Aarohan Pruthi, Yulia Dyachkova, Tarun Puri
October-December 2021, 4(4):634-641
DOI:10.4103/crst.crst_159_21  
  441 32 -
Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer
Sachin Dhumal, Vijay Patil, Vanita Noronha, Amit Joshi, Nandini Menon, Kavita Nawale, Rupali Tambe, Kumar Prabhash
October-December 2021, 4(4):642-646
DOI:10.4103/crst.crst_157_21  
  414 37 -
The utility of day 14 bone marrow response assessment in patients undergoing acute myeloid leukemia induction: A single institution retrospective experience
Avaronnan Manuprasad, Vineetha Raghavan, Praveen Kumar Shenoy, Aswathi Krishnan, Chandran K Nair
October-December 2021, 4(4):628-633
DOI:10.4103/crst.crst_90_21  
  414 33 -
ORIGINAL ARTICLE: GERIATRIC ONCOLOGY SECTION
Utilization of technology among older Indian patients with cancer: A cross-sectional study
Abhijith Rajaram Rao, Shreya Gattani, Renita Castelino, Sharath Kumar, Ratan Dhekale, Jyoti Krishnamurthy, Anant Ramaswamy, Vanita Noronha, Vikram Gota, Shripad Banavali, Rajendra A Badwe, Kumar Prabhash
October-December 2021, 4(4):656-662
DOI:10.4103/crst.crst_290_21  
  374 35 -
REVIEW ARTICLES
Management of triple-negative breast cancer in the era of novel therapies: A narrative review
Rakesh Kumar Sharma, Ajay Gogia
October-December 2021, 4(4):668-676
DOI:10.4103/crst.crst_226_21  
  356 52 -
ORIGINAL ARTICLE: REAL WORLD DATA
Neoadjuvant chemoradiotherapy followed by surgery for operable carcinoma esophagus: Ground reality in a tertiary care center of rural India - A retrospective audit
Tapas Kumar Dora, Tushar Aeron, Abhishek Chatterjee, Jayashree Deshmukh, Alok Goel, Shubhadeep Bose, Debashish Chaudhary, Rakesh Sharma, Sachin Khandelwal, Sankalp Sancheti, Shefali Pahwa, Avtar Singh, Amit Saini, Sarbani Ghosh Laskar, Jai Prakash Agarwal, Shyam Kishore Shrivastava, Rakesh Kapoor
October-December 2021, 4(4):647-655
DOI:10.4103/crst.crst_147_21  
  336 28 1
EDITORIALS
Melanoma: Gaps in knowledge and treatment
Anand Raja, Chandra Kumar Krishnan
October-December 2021, 4(4):728-730
DOI:10.4103/crst.crst_311_21  
  318 20 -
REVIEW ARTICLES
Imaging-based T stage (iT) as a predictive and prognostic marker for outcome in T4 stage tongue carcinomas: A narrative review
Abhishek Mahajan, Meena Suthar, Ujjwal Agarwal, Shreya Shukla, Shivakumar Thiagarajan, Nilesh Sable
October-December 2021, 4(4):677-683
DOI:10.4103/crst.crst_132_21  
  306 22 -
Application of augmented and virtual reality in cigarette smoking cessation: A systematic review
S Canty Sandra, R Anusha, PD Madankumar
October-December 2021, 4(4):684-691
DOI:10.4103/crst.crst_192_21  
  284 26 -
DRUG REVIEW
Lenvatinib: A narrative drug review
Alok Goel, Anshul Singla
October-December 2021, 4(4):709-720
DOI:10.4103/crst.crst_151_21  
  264 30 -
REVIEW ARTICLES
Impact of epidermal growth factor receptor T790M testing in relapsed non-small cell lung cancer: A narrative review of the T790M reflex testing algorithm
Kumar Prabhash, Ullas Batra
October-December 2021, 4(4):692-701
DOI:10.4103/crst.crst_169_21  
  262 29 -
MOLECULAR TUMOR BOARD
FGFR alterations in head-and-neck cancer
Goutam Santosh Panda, Vanita Noronha, Omshree Shetty, Asawari Patil, Vijay Patil, Pratik Chandrani, Anuradha Chougule, Kumar Prabhash
October-December 2021, 4(4):737-746
DOI:10.4103/crst.crst_297_21  
  264 25 -
EDITORIALS
(F)utility of day 14 bone marrow in acute myeloid leukemia on 3 + 7 induction – Is it time to bid adieu to day 14 bone marrow?
Sumeet Prakash Mirgh
October-December 2021, 4(4):731-733
DOI:10.4103/crst.crst_283_21  
  268 15 -
REVIEW ARTICLE-BIOMARKER SERIES
RET in non-small cell lung carcinoma: A narrative review
Shrinidhi Nathany, Himanshi Diwan, Ullas Batra
October-December 2021, 4(4):702-708
DOI:10.4103/crst.crst_254_21  
  252 23 -
LETTERS TO EDITOR
The apt way forward to reduce the economic burden is enhancing utilization amongst eligible beneficiaries
Gopal Ashish Sharma, Vijay Kumar Barwal, Sumala Kapila
October-December 2021, 4(4):763-764
DOI:10.4103/crst.crst_296_21  
  248 21 -
STATISTICAL RESOURCE
To “P” or not to “P”, that is the question: A narrative review on P value
HS Darling
October-December 2021, 4(4):756-762
DOI:10.4103/crst.crst_222_21  
  230 21 -
IMAGE CHALLENGES
Grapevines in the neck
Antariksh Vijan, Aashna Karbhari, Abhishek Mahajan
October-December 2021, 4(4):747-751
DOI:10.4103/crst.crst_223_21  
  228 20 -
A rare tumor of the large bowel in a young boy
Shyam Srinivasan, Soumitra Saha
October-December 2021, 4(4):752-755
DOI:10.4103/crst.crst_186_21  
  222 16 -
LETTERS TO EDITOR
Pembrolizumab in recurrent or metastatic cervical cancer
Shuvadeep Ganguly, Ajay Gogia
October-December 2021, 4(4):808-809
DOI:10.4103/crst.crst_316_21  
  218 16 -
EDITORIALS
At crossroads with CROSS: Implementing the CROSS protocol in a resource-limited setting
Senthil J Rajappa
October-December 2021, 4(4):734-736
DOI:10.4103/crst.crst_279_21  
  212 13 -
LETTERS TO EDITOR
Cigarettes are killers that travel in “packs”: A physician's perspective
Pratik Biswas
October-December 2021, 4(4):765-767
DOI:10.4103/crst.crst_281_21  
  200 20 1
EDITORIALS
Predicting pathological complete response post neoadjuvant chemotherapy and personalizing therapy in breast cancer
Rajendra A Badwe, Vani Parmar, Nita S Nair
October-December 2021, 4(4):726-727
DOI:10.4103/crst.crst_310_21  
  200 16 -
LETTERS TO EDITOR
Increasing incidence of colorectal cancer among Indians: Concerns and the way forward
Nabendu Murmu, Debarpan Mitra, Gaurav Das
October-December 2021, 4(4):771-772
DOI:10.4103/crst.crst_258_21  
  194 18 1
Authors' reply to Tripathi et al., Majumdar and Mirnezami
Tasneef Zargar, Dinesh Kumar, Bhavna Sahni
October-December 2021, 4(4):781-782
DOI:10.4103/crst.crst_299_21  
  200 10 -
Risk of cardiovascular events after combined modality therapy for early-stage favorable Hodgkin's lymphoma: Low but not zero
Kaveri Joshi, Suvir Singh
October-December 2021, 4(4):807-808
DOI:10.4103/crst.crst_282_21  
  194 14 -
Diet and colorectal cancers
Mayank Tripathi, Durgatosh Pandey, Saumya Chopra
October-December 2021, 4(4):778-779
DOI:10.4103/crst.crst_247_21  
  191 15 1
PATIENT/CAREGIVER CORNER
Cancer - Not a sin but a disease
Anonymous
October-December 2021, 4(4):664-665
DOI:10.4103/crst.crst_257_21  
  186 15 -
RESIDENT CORNER
The process of unlearning
Dharmishtha Ashis Basu, Anindya Mukherjee, Abhinav Dewan, Sekhar Saha
October-December 2021, 4(4):721-722
DOI:10.4103/crst.crst_255_21  
  184 14 -
LETTERS TO EDITOR
Precision radiotherapy in carcinoma esophagus: Does conformity translate into significant clinical outcomes?
Sambit Swarup Nanda, Ashutosh Mukherji, Satyajit Pradhan
October-December 2021, 4(4):773-774
DOI:10.4103/crst.crst_245_21  
  182 12 1
Old targets, new bullets, nursing fresh hope
Pradeep Ventrapati
October-December 2021, 4(4):788-789
DOI:10.4103/crst.crst_250_21  
  178 15 2
Authors' reply to Ghosh et al. and Biswas
Koushik Chatterjee, Amitabh Ray, Arup Chakraborty
October-December 2021, 4(4):767-768
DOI:10.4103/crst.crst_312_21  
  184 9 -
Smoking oncologists – Hippocrates or hypocrites?
Indranil Ghosh, Rajib Bhattacharjee
October-December 2021, 4(4):764-765
DOI:10.4103/crst.crst_249_21  
  181 12 1
PIK3CA alterations in non-small cell lung carcinoma: A puzzle yet to be solved
Annie Kanchan Baa, Prabhat Singh Malik
October-December 2021, 4(4):797-799
DOI:10.4103/crst.crst_260_21  
  178 14 -
Geriatric assessment to improve overall geriatric oncology outcomes: The need of the hour in resource-limited settings
Nikita Mehra, Srinivas Chilukuri
October-December 2021, 4(4):795-796
DOI:10.4103/crst.crst_273_21  
  180 11 1
Authors' reply to Nanda et al. and Mathew
Tapas Kumar Dora, Jayashree Deshmukh, Abhishek Chatterjee
October-December 2021, 4(4):775-777
DOI:10.4103/crst.crst_277_21  
  176 14 -
Toward precision nutrition in the fight against colorectal cancer
Reza Mirnezami
October-December 2021, 4(4):777-778
DOI:10.4103/crst.crst_243_21  
  176 12 1
Diet and colorectal cancer: Eat, pray, and live with the consequences
Swaratika Majumdar
October-December 2021, 4(4):779-780
DOI:10.4103/crst.crst_263_21  
  176 12 1
Gestational trophoblastic neoplasia: A road less travelled
Anuj Gupta, Akhil Kapoor
October-December 2021, 4(4):786-787
DOI:10.4103/crst.crst_278_21  
  172 12 1
Nivolumab in relapsed malignant mesothelioma: Is it ‘CONFIRM’ed?
Archana Sasi, Ajay Gogia
October-December 2021, 4(4):809-810
DOI:10.4103/crst.crst_317_21  
  166 16 -
POETRY IN ONCOLOGY
Blighted breath in a bereft lung- A poignant reflection of a COVID loss
Vishal Jayakar
October-December 2021, 4(4):663-663
DOI:10.4103/crst.crst_239_21  
  170 10 -
LETTERS TO EDITOR
To bridge the last-mile gap
Venugopalan Gunasekaran
October-December 2021, 4(4):793-794
DOI:10.4103/crst.crst_242_21  
  172 7 1
Long-term venous access devices: A lifeline for patients with cancer
Rushabh Kothari
October-December 2021, 4(4):769-770
DOI:10.4103/crst.crst_259_21  
  168 10 1
PATIENT/CAREGIVER CORNER
The fight is on...until we win
Tarunima Malik Grover
October-December 2021, 4(4):666-667
DOI:10.4103/crst.crst_270_21  
  167 10 -
LETTERS TO EDITOR
Authors' reply to Kothari and Niyogi et al.
Nizamudheen Mangalassery Pareeekutty, Jashma Chandveettil
October-December 2021, 4(4):770-770
DOI:10.4103/crst.crst_288_21  
  162 13 -
Totally implantable venous access devices: Handle with care!
Devayani Niyogi, Virendra Tiwari
October-December 2021, 4(4):768-769
DOI:10.4103/crst.crst_265_21  
  166 9 -
Universal Immunization Program in India: Time for covering patients with cancer?
Aparna Gangopadhyay
October-December 2021, 4(4):803-804
DOI:10.4103/crst.crst_240_21  
  162 9 -
Authors' reply to Gupta et al.
Joydeep Ghosh, Sandip Ganguly, Bivas Biswas
October-December 2021, 4(4):787-788
DOI:10.4103/crst.crst_295_21  
  160 11 -
Transitioning from 3DCRT to volumetric modulated arc therapy: Is more really better?
Ashwathy Susan Mathew
October-December 2021, 4(4):774-775
DOI:10.4103/crst.crst_253_21  
  160 11 1
Authors' reply to Paramanandhan et al. and Shankar et al.
Adhara Chakraborty, Shivakumar Thiagarajan, Devendra Chaukar
October-December 2021, 4(4):785-786
DOI:10.4103/crst.crst_298_21  
  160 10 -
Batra et al.'s reply to Ventrapati and Gheware et al.
Ullas Batra, Shrinidhi Nathany, Himanshi Diwan
October-December 2021, 4(4):790-791
DOI:10.4103/crst.crst_276_21  
  158 12 -
Need more evidence for establishing standard vaccination practices among patients with cancer
Sharmila Pimple, Gauravi Ashish Mishra
October-December 2021, 4(4):804-805
DOI:10.4103/crst.crst_280_21  
  160 10 -
Authors' reply to Verma et al., Gupta et al., and Baa et al.
Akhil Kapoor, Amit Kumar, Kumar Prabhash
October-December 2021, 4(4):802-803
DOI:10.4103/crst.crst_286_21  
  158 12 -
Sarcomatoid variant of squamous cell carcinoma of the head-and-neck: Need for aggressive management
Ravi Shankar, Aseem Mishra, Bhavya B Reddy
October-December 2021, 4(4):783-784
DOI:10.4103/crst.crst_246_21  
  158 11 1
Authors' reply to Murmu et al.
Henisha T Tahiliani, Asha P Purohit, Shashank C Desai, Puja Bhavesh Jarwani
October-December 2021, 4(4):772-773
DOI:10.4103/crst.crst_268_21  
  160 9 -
Comprehensive genomic profiling of lung cancer: A key to better clinical management
Parul Gupta, Amanjit Bal, Navneet Singh
October-December 2021, 4(4):799-800
DOI:10.4103/crst.crst_252_21  
  156 9 -
Kapoor's reply to Ventrapati and Gheware et al.
Akhil Kapoor
October-December 2021, 4(4):791-792
DOI:10.4103/crst.crst_287_21  
  151 12 -
Sarcomatoid variant of head.and.neck tumors: Known is a drop, unknown is an ocean
Murali Paramanandhan, Anil M R Kumar, KP Sangeetha
October-December 2021, 4(4):782-783
DOI:10.4103/crst.crst_272_21  
  156 7 1
Geriatric Assessment- A pressing priority for streamlining care for older patients with cancer
Joyita Banerjee, Abhijith Rajaram Rao
October-December 2021, 4(4):792-793
DOI:10.4103/crst.crst_264_21  
  150 12 -
Authors' reply to Banerjee et al., Gunasekaran, and Mehra et al.
Vanita Noronha, Anant Ramaswamy, Kumar Prabhash
October-December 2021, 4(4):796-797
DOI:10.4103/crst.crst_302_21  
  149 13 -
Concurrent PIK3CA mutation: A cause for primary resistance to epidermal growth factor receptor tyrosine kinase inhibitors or an acquired phenomenon?
Amit Verma, Umut Disel, Jatinder Kaur
October-December 2021, 4(4):800-802
DOI:10.4103/crst.crst_256_21  
  150 9 1
From bench to bedside and beyond: Challenges in direct KRAS targeting
Atish Prabhakar Gheware, Amber Rathor, Deepali Jain
October-December 2021, 4(4):789-790
DOI:10.4103/crst.crst_248_21  
  150 8 -
Cabozantinib for radioiodine-refractory progressive differentiated thyroid cancer
Shuvadeep Ganguly, Ajay Gogia
October-December 2021, 4(4):806-806
DOI:10.4103/crst.crst_234_21  
  146 11 -